Advertisement

Topics

FDA signals crack down on controversial painkiller

04:31 EST 15 Nov 2017 | Pharmafile

Scott Gottlieb, the FDA’s Commissioner, issued an advisory about the medicinal plant-product known as kratom. The plant is known to act as a stimulant in low-doses and has opioid-like effects in higher doses, but whether it is directly harmful is a matter of serious debate.

The plant has been used in Asia, where it originates, as a natural remedy for numerous ailments and, like the coca plant in Central and South America, has been used as a stimulant by labourers to maintain energy for centuries.

read more

Original Article: FDA signals crack down on controversial painkiller

NEXT ARTICLE

More From BioPortfolio on "FDA signals crack down on controversial painkiller"

Advertisement
Quick Search
Advertisement
Advertisement